Wolverine Trading, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $623,255 - $920,080	15,500 New	15,500 $861,000
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $318,348 - $397,306	7,400 New	7,400 $345,000
Q3 2023 Nov 15, 2023	BUY	$34.92 - $46.66 $34,920 - $46,660	1,000 Added 11.49%	9,700 $345,000
Q2 2023 Aug 23, 2023	SELL	$37.35 - $52.15 $3,735 - $5,215	-100 Reduced 1.14%	8,700 $401,000
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $325,512 - $428,648	8,800 New	8,800 $340,000
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $194,800 - $256,000	2,500 New	2,500 $215,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.